$1 Trial Offer - Realtime Screener -- Try out our Realtime Product, GetStockIdeas. The advanced screener tool is a momentum trader's dream!

ARCA biopharma, Inc.
(NASDAQ : ABIO)

( )
ABIO After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Loading ABIO News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.39%79.771.3%$810.55m
BIIBBiogen Inc.
0.43%308.171.2%$594.94m
AMGNAmgen Inc.
1.02%171.971.1%$507.80m
CELGCelgene Corporation
0.82%108.790.8%$480.49m
MDVNMedivation, Inc.
0.14%80.351.5%$457.05m
REGNRegeneron Pharmaceuticals, Inc.
0.68%402.973.4%$311.23m
ILMNIllumina, Inc.
1.61%172.214.2%$212.71m
ALXNAlexion Pharmaceuticals, Inc.
0.36%129.632.7%$186.81m
BMRNBioMarin Pharmaceutical Inc.
1.32%96.224.2%$183.84m
VRTXVertex Pharmaceuticals Incorporated
0.74%97.092.2%$112.19m
INCYIncyte Corporation
1.17%81.042.5%$106.31m
IONSIonis Pharmaceuticals, Inc.
1.75%30.9011.4%$96.76m
AAgilent Technologies, Inc.
0.13%47.320.9%$93.68m
TSROTESARO, Inc.
1.44%86.4616.2%$88.66m
EXASExact Sciences Corporation
0.74%19.1922.9%$86.20m

Company Profile

ARCA biopharma, Inc. is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. The company's business combines expertise in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, GencaroTM is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. ARCA biopharma was founded in 1992 and is headquartered in Westminster, CO.